The path to success isn't always smooth. When you come across inevitable bumps in the road, it's easy to lose sight of your destination. Luckily, you're far from the first person to experience those ...

At 30 years old, Nick CliffOrr has accomplished one of his most ambitious goals – qualifying for the Ultra-Trail du ...

The stress and overwhelm of world events can cause you to lose your zest for life, your motivation to do anything. Here's ...

The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

Jo Lemoine said she refuses to let cancer take her down. “I’m just full of gratitude, and I can’t wait to get back to work." ...

MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...

On Thursday, November 14, the European Commission decided to refer Romania and Bulgaria to the Court of Justice of the ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...